Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 341031-54-7
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15DAY
Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram
Supply Ability: G,KG,TON
Appearance:: |
Powder |
CAS NO:: |
341031-54-7 |
Molecular Formula:: |
C26H33FN4O7 |
Molecular Weight:: |
532.56100 |
EINECS NO:: |
638-825-9 |
MDL NO:: |
MFCD08282795 |
Appearance:: |
Powder |
CAS NO:: |
341031-54-7 |
Molecular Formula:: |
C26H33FN4O7 |
Molecular Weight:: |
532.56100 |
EINECS NO:: |
638-825-9 |
MDL NO:: |
MFCD08282795 |
Product Description:
Product Name: Sunitinib Malate CAS NO: 341031-54-7
Synonyms:
sunitinib L-malic acid salt;
sunitynib L-malate;
L-malic acid salt of sunitinib;
Chemical & Physical Properties:
Appearance: Powder
Assay :≥99.00%
Density: 1.229g/cm3
Boiling Point: 572.1℃ at 760mmHg
Flash Point: 299.8℃
Refractive Index: n20/D 1.455(lit.)
Safety Information:
Safety Statements: S24/25
WGK Germany: 3
Risk Statements: R36/37/38
Hazard Code: T
Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
